Cancer Types


  • CAR T-cell Therapy: Understanding the Warning and the Risks

    The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

    by Sandra Gordon

  • Survivor Profile

    A Can-Do Spirit

    Navy veteran and two-time cancer survivor Bruce Wright helps other veterans secure benefits for their health conditions.

    by Lindsey Konkel Neabore

  • Living With Chronic Blood Cancer

    Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.

    by Kendall K. Morgan

  • Q&A

    Pulling Back the Research Curtain

    Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.

    by Marci A. Landsmann

  • Taking Stock of CAR T-Cell Therapy

    Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.

    by Kendall K. Morgan

  • Comorbidity: Treating the Whole Patient

    Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.

    by Eric Fitzsimmons

  • Cracking the Code of Acute Myeloid Leukemia

    Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.

    by Kendall K. Morgan

  • Forward Look

    CAR T Cells for Blood Cancer Patients

    Researchers aim to minimize disease relapses by targeting multiple proteins.

    by Erin O'Donnell

  • Survivor Profile

    Breaking Down Barriers

    Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.

    by Bradley Jones

  • More Data on COVID-19 Vaccination and Cancer

    Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

    by Anna Goshua